These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

298 related items for PubMed ID: 9581779

  • 1. Reduced HIV-1 infectability of CD4+ lymphocytes from exposed-uninfected individuals: association with low expression of CCR5 and high production of beta-chemokines.
    Paxton WA, Liu R, Kang S, Wu L, Gingeras TR, Landau NR, Mackay CR, Koup RA.
    Virology; 1998 Apr 25; 244(1):66-73. PubMed ID: 9581779
    [Abstract] [Full Text] [Related]

  • 2. The HIV type 1 coreceptor CCR5 and its role in viral transmission and disease progression.
    Paxton WA, Kang S, Koup RA.
    AIDS Res Hum Retroviruses; 1998 Apr 25; 14 Suppl 1():S89-92. PubMed ID: 9581891
    [Abstract] [Full Text] [Related]

  • 3. IFN-gamma and IL-12 differentially regulate CC-chemokine secretion and CCR5 expression in human T lymphocytes.
    Losana G, Bovolenta C, Rigamonti L, Borghi I, Altare F, Jouanguy E, Forni G, Casanova JL, Sherry B, Mengozzi M, Trinchieri G, Poli G, Gerosa F, Novelli F.
    J Leukoc Biol; 2002 Oct 25; 72(4):735-42. PubMed ID: 12377943
    [Abstract] [Full Text] [Related]

  • 4. CC chemokine receptor 5 cell-surface expression in relation to CC chemokine receptor 5 genotype and the clinical course of HIV-1 infection.
    de Roda Husman AM, Blaak H, Brouwer M, Schuitemaker H.
    J Immunol; 1999 Oct 15; 163(8):4597-603. PubMed ID: 10510404
    [Abstract] [Full Text] [Related]

  • 5. HIV-1 infectability of CD4+ lymphocytes with relation to beta-chemokines and the CCR5 coreceptor.
    Paxton WA, Kang S, Liu R, Landau NR, Gingeras TR, Wu L, Mackay CR, Koup RA.
    Immunol Lett; 1999 Mar 15; 66(1-3):71-5. PubMed ID: 10203036
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of CCR5 expression by IL-12 through induction of beta-chemokines in human T lymphocytes.
    Wang J, Guan E, Roderiquez G, Norcross MA.
    J Immunol; 1999 Dec 01; 163(11):5763-9. PubMed ID: 10570258
    [Abstract] [Full Text] [Related]

  • 7. Persistent resistance to HIV-1 infection in CD4 T cells from exposed uninfected Vietnamese individuals is mediated by entry and post-entry blocks.
    Sáez-Cirión A, Versmisse P, Truong LX, Chakrabarti LA, Carpentier W, Barré-Sinoussi F, Scott-Algara D, Pancino G.
    Retrovirology; 2006 Nov 08; 3():81. PubMed ID: 17092330
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effect of influenza virus vaccine on the expression of human immunodeficiency virus co-receptor CCR5.
    Rucker RP, Day NK, Good RA, Kamchaisatian W, Emmanuel P, Sleasman JW, Mayeski C, Dinglasan E, Haraguchi S, Tangsinmankong N.
    Ann Allergy Asthma Immunol; 2004 Sep 08; 93(3):272-6. PubMed ID: 15478388
    [Abstract] [Full Text] [Related]

  • 10. Isolated human astrocytes are not susceptible to infection by M- and T-tropic HIV-1 strains despite functional expression of the chemokine receptors CCR5 and CXCR4.
    Boutet A, Salim H, Taoufik Y, Lledo PM, Vincent JD, Delfraissy JF, Tardieu M.
    Glia; 2001 May 08; 34(3):165-77. PubMed ID: 11329179
    [Abstract] [Full Text] [Related]

  • 11. Natural killer cells from human immunodeficiency virus (HIV)-infected individuals are an important source of CC-chemokines and suppress HIV-1 entry and replication in vitro.
    Oliva A, Kinter AL, Vaccarezza M, Rubbert A, Catanzaro A, Moir S, Monaco J, Ehler L, Mizell S, Jackson R, Li Y, Romano JW, Fauci AS.
    J Clin Invest; 1998 Jul 01; 102(1):223-31. PubMed ID: 9649576
    [Abstract] [Full Text] [Related]

  • 12. The efficiency of R5 HIV-1 infection is determined by CD4 T-cell surface CCR5 density through G alpha i-protein signalling.
    Lin YL, Mettling C, Portalès P, Réant B, Robert-Hebmann V, Reynes J, Clot J, Corbeau P.
    AIDS; 2006 Jun 26; 20(10):1369-77. PubMed ID: 16791011
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Progesterone-induced inhibition of chemokine receptor expression on peripheral blood mononuclear cells correlates with reduced HIV-1 infectability in vitro.
    Vassiliadou N, Tucker L, Anderson DJ.
    J Immunol; 1999 Jun 15; 162(12):7510-8. PubMed ID: 10358206
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Downregulation of CCR5 on activated CD4 T cells in HIV-infected Indians.
    Dubey S, Khalid M, Wesley C, Khan SA, Wanchu A, Jameel S.
    J Clin Virol; 2008 Sep 15; 43(1):25-31. PubMed ID: 18462992
    [Abstract] [Full Text] [Related]

  • 17. Heterozygosity for a defective gene for CC chemokine receptor 5 is not the sole determinant for the immunologic and virologic phenotype of HIV-infected long-term nonprogressors.
    Cohen OJ, Vaccarezza M, Lam GK, Baird BF, Wildt K, Murphy PM, Zimmerman PA, Nutman TB, Fox CH, Hoover S, Adelsberger J, Baseler M, Arthos J, Davey RT, Dewar RL, Metcalf J, Schwartzentruber DJ, Orenstein JM, Buchbinder S, Saah AJ, Detels R, Phair J, Rinaldo C, Margolick JB, Pantaleo G, Fauci AS.
    J Clin Invest; 1997 Sep 15; 100(6):1581-9. PubMed ID: 9294127
    [Abstract] [Full Text] [Related]

  • 18. Differential effects of CD40 ligand/trimer stimulation on the ability of dendritic cells to replicate and transmit HIV infection: evidence for CC-chemokine-dependent and -independent mechanisms.
    McDyer JF, Dybul M, Goletz TJ, Kinter AL, Thomas EK, Berzofsky JA, Fauci AS, Seder RA.
    J Immunol; 1999 Mar 15; 162(6):3711-7. PubMed ID: 10092834
    [Abstract] [Full Text] [Related]

  • 19. Human immunodeficiency virus type 1 infection of antigen-specific CD4 cytotoxic T lymphocytes.
    Robbins PA, Roderiquez GL, Peden KW, Norcross MA.
    AIDS Res Hum Retroviruses; 1998 Nov 01; 14(16):1397-406. PubMed ID: 9824317
    [Abstract] [Full Text] [Related]

  • 20. Regulation of CCR5 and CXCR4 expression by type 1 and type 2 cytokines: CCR5 expression is downregulated by IL-10 in CD4-positive lymphocytes.
    Patterson BK, Czerniewski M, Andersson J, Sullivan Y, Su F, Jiyamapa D, Burki Z, Landay A.
    Clin Immunol; 1999 Jun 01; 91(3):254-62. PubMed ID: 10370370
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.